申请人:Glaxo Inc.
公开号:US05426196A1
公开(公告)日:1995-06-20
The present Invention includes synthetic steps and intermediates involved in the following reaction scheme a of converting compounds of Formula (II) to the diarylmethanes of Formula (I): ##STR1## wherein: Y is oxygen or sulfur; A, B, C, D, and E are carbon or 1, 2 or 3 of A, B, C, D, and E are independently nitrogen, and the others are carbon; and wherein R.sup.1 through R.sup.10 are selected independently from the group consisting of: hydrogen, hydroxy, alkyl, C.sub.3 -C.sub.8 cycloalkyl, C.sub.3 -C.sub.8 cycloalkyl alkyl, alkenyl, hydroxy alkyl, alkoxy alkyl, perhalo-alkyl, amino, nitro, nitrile, halo, carboxyl, sulfonyl, acyl, formyl, carbamoyl, trifluoromethyl, aminomethyl, azido, amido, hydrazino, aryl, aryloxy, heteroaryl, or aryl or heteroaryl, mono, di, or tri substituted with one or more hydrogen, hydroxy, alkyl, C.sub.3 -C.sub.8 cycloalkyl, C.sub.3 -C.sub.8 cycloalkyl alkyl, alkenyl, hydroxy alkyl, alkoxy alkyl, perhaloalkyl, amino, nitro, nitrile, halo, carboxyl, sulfonyl, acyl, formyl, carbamoyl, trifluoromethyl, aminomethyl, azido, amido, hydrazino, aryl, aryloxy, or heteroaryl groups and; the pharmaceutically acceptable salts and solvates thereof.
本发明涉及以下反应方案a中涉及的合成步骤和中间体,将化合物II的化合物转化为化合物I的二苯甲烷:##STR1## 其中:Y为氧或硫;A、B、C、D和E为碳或A、B、C、D和E中的1、2或3个独立地为氮,其余为碳;R.sup.1至R.sup.10独立地选自以下组中的一种或多种:氢、羟基、烷基、C.sub.3-C.sub.8环烷基、C.sub.3-C.sub.8环烷基烷基、烯基、羟基烷基、烷氧基烷基、全卤基、氨基、硝基、腈基、卤基、羧基、磺酰基、酰基、甲酰基、氨基甲基、叠氮基、酰胺基、肼基、芳基、芳氧基、杂芳基、或带有一个或多个氢、羟基、烷基、C.sub.3-C.sub.8环烷基、C.sub.3-C.sub.8环烷基烷基、烯基、羟基烷基、烷氧基烷基、全卤基、氨基、硝基、腈基、卤基、羧基、磺酰基、酰基、甲酰基、氨基甲基、叠氮基、酰胺基、肼基、芳基、芳氧基或杂芳基的单个、双个或三个取代基,以及其制药上可接受的盐和溶剂化物。